These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20071036)

  • 21. Composite International Diagnostic Interview screening scales for DSM-IV anxiety and mood disorders.
    Kessler RC; Calabrese JR; Farley PA; Gruber MJ; Jewell MA; Katon W; Keck PE; Nierenberg AA; Sampson NA; Shear MK; Shillington AC; Stein MB; Thase ME; Wittchen HU
    Psychol Med; 2013 Aug; 43(8):1625-37. PubMed ID: 23075829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The performance of the K6 and K10 screening scales for psychological distress in the Australian National Survey of Mental Health and Well-Being.
    Furukawa TA; Kessler RC; Slade T; Andrews G
    Psychol Med; 2003 Feb; 33(2):357-62. PubMed ID: 12622315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The psychometric properties of the 10-item Kessler Psychological Distress Scale (K10) in Canadian military personnel.
    Sampasa-Kanyinga H; Zamorski MA; Colman I
    PLoS One; 2018; 13(4):e0196562. PubMed ID: 29698459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Rheumatoid Arthritis.
    Hitchon CA; Zhang L; Peschken CA; Lix LM; Graff LA; Fisk JD; Patten SB; Bolton J; Sareen J; El-Gabalawy R; Marriott J; Bernstein CN; Marrie RA
    Arthritis Care Res (Hoboken); 2020 Aug; 72(8):1130-1139. PubMed ID: 31199570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for anxiety and depression in primary care with the Duke Anxiety-Depression Scale.
    Parkerson GR; Broadhead WE
    Fam Med; 1997 Mar; 29(3):177-81. PubMed ID: 9085098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of depressive and anxiety disorders and validation of the Hospital Anxiety and Depression Scale as a screening tool in axial spondyloarthritis patients.
    Chan CYY; Tsang HHL; Lau CS; Chung HY
    Int J Rheum Dis; 2017 Mar; 20(3):317-325. PubMed ID: 25293872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of the psychometric properties of the Beck Depression Inventory-II, the Montgomery and Åsberg Depression Rating Scale, and the Hospital Anxiety and Depression Scale in a sample from a healthy population.
    Kjaergaard M; Arfwedson Wang CE; Waterloo K; Jorde R
    Scand J Psychol; 2014 Feb; 55(1):83-9. PubMed ID: 24256317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validity of the five-item mental health inventory for screening current mood and anxiety disorders in the general population.
    Ten Have M; Van Bon-Martens MJH; Schouten F; Van Dorsselaer S; Shields-Zeeman L; Luik AI
    Int J Methods Psychiatr Res; 2024 Sep; 33(3):e2030. PubMed ID: 38956889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detecting depression after pregnancy: the validity of the K10 and K6 in Burkina Faso.
    Baggaley RF; Ganaba R; Filippi V; Kere M; Marshall T; Sombié I; Storeng KT; Patel V
    Trop Med Int Health; 2007 Oct; 12(10):1225-9. PubMed ID: 17956505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depression and anxiety among coronary heart disease patients: can affect dimensions and theory inform diagnostic disorder-based screening?
    Tully PJ; Penninx BW
    J Clin Psychol; 2012 Apr; 68(4):448-61. PubMed ID: 22308051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for anxiety and depression in dialysis patients: comparison of the Hospital Anxiety and Depression Scale and the Beck Depression Inventory.
    Preljevic VT; Østhus TB; Sandvik L; Opjordsmoen S; Nordhus IH; Os I; Dammen T
    J Psychosom Res; 2012 Aug; 73(2):139-44. PubMed ID: 22789418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does presence of metabolic syndrome impact anxiety and depressive disorder screening results in middle aged and elderly individuals? A population based study.
    Butnoriene J; Steibliene V; Saudargiene A; Bunevicius A
    BMC Psychiatry; 2018 Jan; 18(1):5. PubMed ID: 29310620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concordance between symptom screening and diagnostic procedure: the Hopkins Symptom Checklist-25 and the Composite International Diagnostic Interview I.
    Sandanger I; Moum T; Ingebrigtsen G; Dalgard OS; Sørensen T; Bruusgaard D
    Soc Psychiatry Psychiatr Epidemiol; 1998 Jul; 33(7):345-54. PubMed ID: 9689897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The validity of military screening for mental health problems: diagnostic accuracy of the PCL, K10 and AUDIT scales in an entire military population.
    Searle AK; Van Hooff M; McFarlane AC; Davies CE; Fairweather-Schmidt AK; Hodson SE; Benassi H; Steele N
    Int J Methods Psychiatr Res; 2015 Mar; 24(1):32-45. PubMed ID: 25511518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Four-Dimensional Symptom Questionnaire (4DSQ) in the general population: scale structure, reliability, measurement invariance and normative data: a cross-sectional survey.
    Terluin B; Smits N; Brouwers EP; de Vet HC
    Health Qual Life Outcomes; 2016 Sep; 14(1):130. PubMed ID: 27629535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validity of the Brief Symptom Inventory-18 (BSI-18) for identifying depression and anxiety in young adult cancer survivors: Comparison with a Structured Clinical Diagnostic Interview.
    Recklitis CJ; Blackmon JE; Chang G
    Psychol Assess; 2017 Oct; 29(10):1189-1200. PubMed ID: 28080106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for epilepsy-specific anxiety symptoms: French validation of the EASI.
    Micoulaud-Franchi JA; Kotwas I; Arthuis M; Soncin L; Rontani P; Daquin G; Cermolacce M; Bartolomei F; McGonigal A
    Epilepsy Behav; 2022 Mar; 128():108585. PubMed ID: 35180578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Panic Disorder Severity Scale: reliability and validity of the Turkish version.
    Monkul ES; Tural U; Onur E; Fidaner H; Alkin T; Shear MK
    Depress Anxiety; 2004; 20(1):8-16. PubMed ID: 15368591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The validity and reliability of screening measures for depression and anxiety disorders in multiple sclerosis.
    Marrie RA; Zhang L; Lix LM; Graff LA; Walker JR; Fisk JD; Patten SB; Hitchon CA; Bolton JM; Sareen J; El-Gabalawy R; Marriott JJ; Bernstein CN
    Mult Scler Relat Disord; 2018 Feb; 20():9-15. PubMed ID: 29274564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. German translation and validation of the brief Epilepsy Anxiety Survey Instrument (brEASI).
    Michaelis R; Schlömer S; Popkirov S; Krämer G; Lindemann A; Cosentino M; Reuber M; Heinen G; Wellmer J; Grönheit W; Wehner T; Schlegel U; Scott AJ; Gandy M
    Epilepsy Behav; 2022 Sep; 134():108857. PubMed ID: 35907288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.